|
|
|
|
Archives
|
Entry
|
Author
|
Date
|
Location
|
|
SD Life Sciences News: Auspex, BrainCells, and J&J’s Startup Center
|
Bruce V. Bigelow |
01/19/12 |
San Diego
|
|
Catabasis Pharmaceuticals Garners $8,000,000 Series A Round
|
VentureDeal |
12/13/11 |
Boston
|
|
Momenta Gets a Steal on Promising Scientific Asset from Once-Hot Virdante
|
Arlene Weintraub |
12/07/11 |
Boston
|
|
Rib-X Pharma Files for IPO
|
Arlene Weintraub |
11/28/11 |
Boston
|
|
Catabasis Begins Human Trials of Omega-3-Inspired Diabetes Treatment
|
Arlene Weintraub |
10/20/11 |
Boston
|
|
VentiRx Concentrates Its Bet on Cancer, and Seattle
|
Luke Timmerman |
09/13/11 |
Seattle
|
|
Inotek Snags $9.3M
|
Erin Kutz |
07/19/11 |
Boston
|
|
Ambit Raises $30M Venture Round, After Pulling Plug on IPO
|
Luke Timmerman |
06/10/11 |
San Diego
|
|
Ambit Biosciences Receives $30,000,000 Series D Funding Round
|
VentureDeal |
06/10/11 |
San Diego
|
|
Ambit Withdraws IPO
|
Bruce V. Bigelow |
06/08/11 |
San Diego
|
|
Pulmatrix Pulls in $5.7M DARPA Grant to Develop Drug Against Respiratory Threats
|
Ryan McBride |
12/14/10 |
Boston
|
|
Ambit Biosciences Seeks $86M IPO as Market Warms Up
|
Luke Timmerman |
11/08/10 |
San Diego
|
|
Ambit Bio Raises $15M
|
Bruce V. Bigelow |
10/19/10 |
San Diego
|
|
VentiRx, With Venti-Sized Ambition to Treat (and Maybe Prevent) Allergies, Passes First Big Test
|
Luke Timmerman |
10/07/10 |
Seattle
|
|
Cisco Acquires ExtendMedia, Genzyme Rejects Sanofi Bid, Yottaa Grabs $4M, & More Boston-Area Deals News
|
Erin Kutz |
09/01/10 |
Boston
|
|
NKT Brings In $4M
|
Erin Kutz |
08/25/10 |
Boston
|
|
Inotek Pharmaceuticals Secures $18,000,000 Series D Financing Round
|
VentureDeal |
06/11/10 |
Boston
|
|
New England Startups Collect $203M in April; Life Sciences and Internet Sectors Top the List
|
Erin Kutz |
05/13/10 |
Boston
|
|
Genzyme Expects to Pay $175M to FDA, Westphal Leaves Sirtris to Run GSK Venture Arm, Gelesis Obesity Treatment Passes First Human Trial, & More Boston-Area Life Sciences News
|
Erin Kutz |
04/23/10 |
Boston
|
|
Catabasis Pharmaceuticals Garners $39,600,000 Series A Funding Round
|
VentureDeal |
04/22/10 |
Boston
|
|
Catabasis Pharmaceuticals Receives $39,600,000 Series A Funding
|
VentureDeal |
04/21/10 |
Boston
|
|
Genzyme Activist Joins Board, Agios Clinches Deal With Celgene, Third Rock Seeks $400M New Fund, & More Boston-Area Life Sciences News
|
Erin Kutz |
04/16/10 |
Boston
|
|
Catabasis Pharmaceuticals Pockets $7.7M out of $40M Venture Round
|
Luke Timmerman |
04/15/10 |
Boston
|
|
Catabasis Pharmaceuticals Secures $7,700,000 New Financing
|
VentureDeal |
04/15/10 |
Boston
|
|
DataSphere and Halosource Get Funded, Sage Signs Up Pfizer, Zymo Raises $90M, & More Seattle-Area Deals News
|
Gregory T. Huang |
01/12/10 |
Seattle
|
|
VentiRx Nabs $25M for Cancer, Allergy Drugs
|
Luke Timmerman |
01/12/10 |
San Diego
|
|
VentiRx Pharmaceuticals Secures $25,000,000 Series A Financing
|
VentureDeal |
01/12/10 |
San Diego
|
|
VLST Cuts Jobs To Preserve Cash, Still Feeding Novo Nordisk Pipeline
|
Luke Timmerman |
12/22/09 |
Seattle
|
|
Vertex and Ironwood Drugs Fare Well in Clinical Trials, Pulmatrix Breathes in $30.2M, IRobot Launches Healthcare Unit, & More Boston-Area Life Sciences News
|
Rebecca Zacks |
11/04/09 |
Boston
|
|
Virdante Pharma Lands $30M in A Round to Combat Inflammation
|
Ryan McBride |
10/29/09 |
Boston
|
|
Page 1 of
2 |
next page » |
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.
© 2007-2012, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Site produced by Andrew Koyfman with design from Rob Hunter.